And when that happens, people ...

And when that happens, a person becomes a carrier of the Faith, but a tool of that faith. Opposites of the above two factors are: uncertainty and inaction. "Uncertainty" is born of the fuzzy goals and the loss of direction. When we do not know what to do (there is no clear purpose), but do need - lack of confidence manifests itself in all its glory. "Inaction" - the fruit and increases the "uncertainty". When there is no make-up a real success, we tend to be disappointed in a way that is elected. Vicious circle, comrades first electronic edition of articles at: http://www.senses.ru/view_news.phtml?ID=6590

Choosing therapy for depression somatized

AV Andryushchenko study of depression in primary care concept is not only confirms the data on the prevalence of this particular form of mental pathology, but also identifies options for this disorder, mimicking somatic pathology (somatization depressive equivalents). There is epidemiological evidence that approximately 30% of the patients outpatient practice with unidentified somatic diagnoses suffer from somatization depression. This mental disorder has a variety of definitions (masked, larvirovannaya, hidden, aleksitimicheskaya, depression without depression), which do not reflect the breadth of the problem. Thus, the known tendency of this form of mood disorder according to the type of depressive neurosis or dysthymia (a chronic type of depression, often starting at a young age and continuing for several years, sometimes indefinitely). Another important aspect is that often patients with depression are convinced of the presence of a rare disease or incompetence of the doctor, insist on lengthy surveys outside psychiatric institutions. In some cases, refusal of treatment by a specialist is due to fear of social consequences. Central component of the treatment somatized dysthymia, according to most authors, is an adequate choice of antidepressant in accordance with standard clinical and therapeutic requirements (efficiency, no violation of the quality of life side effects and addiction, simple therapeutic regimen). The choice of therapy is carried out taking into account such pharmacodynamic parameters of the drug as a relatively short half-life (allowing for the need to replace the drug with no long waiting period) and the rapidity of excretion of metabolites (often responsible for undesirable effects). Despite the experience so far has psychopharmacological, 30 40% of depression is estimated as resistant (no effect in treatment with antidepressants of first choice) or refractory forms (saving pathology using at least two antidepressants of different pharmacological classes). And chodnye data were studied during a 40-year period (1959 1995).. One of the priority of pharmacological agents of choice for somatization affective pathology are monoamine oxidase inhibitors (MAOIs), but most of them (in particular, the irreversible, nonselective MAOI I generation and selective irreversible MAOIs II generation) is now hardly used in connection with severe side effects .